How's the Capital Raise Going to Work?, page-2

First 2 Last

Share
Profile

Follow
dalts66

4,428 Posts.

2059

15/03/23

10:31

Post #: 66772708
Share

Originally posted by fourdollars: ↑

CHM is burning around $5m per quarter. Even with the recent R&D tax rebate, it has less than 2 quarters of funding remaining.

The L1 facility requires that CHM issues shares at a discount to the VWAP of 5 of the previous 30 trading days (selected by L1), so whatever the exact price, its looking like it will be under 7cps.

Current shares on issue: 437m

Raising $30m at 7cps = 429m shares. Plus L1 were already issued 5m shares back in June last year when the funding arrangement was announced. This would leave L1 with approx 50% of the company. I don't think any shareholder can take such a large position without the approval of other shareholders, so not sure how this can work?

The L1 funding agreement announcement did note: "Equity placement facility of up to a total of A$30 million over 24 months with L1 Capital ..... by way of separate placements (the size of whichare subject to certain limits)"

Maybe this is what the clause alludes to - ie there are certain limits to the number of shares that can be issued.

But even if this was capped to under 20% of the company, over 100m shares would still be issued to L1. This would only raise $7m, and not even cover a further 2 quarters of cashburn at CHM. Also, there is the possibility that L1 won't feel comfortable owing such a large percentage of CHM, leading to SP pressure as it reduces its position.

So does Hopper pursue the usual Bell Potter / sophisticated biotech investor route, where he issues discounted shares to nameless entities along with millions of free options? Its been his modus operandi at Imugene, but the last two capital raises there are so far under water it might not be an easy sell here. Might require issuing shares at a massive discount (sub 4c?), and possibly also result is a significant share overhang that puts further downward pressure on the SP.

Hard to see how CHM can be funded for much longer without a huge dilution ....

Expand

If the readout of the 3rd cohort shows promise of disease control or better. we may have the 1st CarT drug that can tackle solid tumour cancer.

That may be the catalyst you are looking for. Remember that the NK trial underway now is of no cost to CHM.

Luckily CHM is run by a group of highly experienced folk. This is not their first rodeo.With the tiny SOI now, and incredibly low market cap for its pipeline. even with dilution now, thd potential of many multiples of upside is still available.

CHM Price at posting: 6.5¢ Sentiment: Buy Disclosure: Held
14 Upvote

2 Great analysis

Reply

Top Stories

RBA holds rates as ALP election campaigning kicks off – expect more political focus

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

HVN

Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate

JDO

Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings

There are more pages in this discussion • 137 more messages in this thread...

First 2 Last

Add CHM (ASX) to my watchlist

(20min delay)
Last 1.2¢		Change 0.002(20.0%)		Mkt cap ! $11.70M

Open	High	Low	Value	Volume
1.0¢	1.3¢	1.0¢	$153.9K	13.87M

Buyers (Bids)

No.	Vol.	Price($)
2	128195	1.1¢

Sellers (Offers)

Price($)	Vol.	No.
1.2¢	1224999	4

View Market Depth

No.	Vol.	Price($)
2	128195	0.011
8	1950000	0.010
13	4788204	0.009
17	5737453	0.008
13	5791427	0.007

Price($)	Vol.	No.
0.012	1224999	4
0.013	1300000	2
0.014	787099	4
0.015	579596	1
0.016	380838	1

Last trade - 16.10pm 05/11/2024 (20 minute delay)

CHM (ASX) Chart

How's the Capital Raise Going to Work?, page-2

RBA holds rates as ALP election campaigning kicks off – expect more political focus

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate

Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

How's the Capital Raise Going to Work?, page-2

Top Stories

RBA holds rates as ALP election campaigning kicks off – expect more political focus

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Harvey Norman may appeal ASIC Federal Court case – the third lawsuit on its plate

Timing will be everything for 'smashing' Hot Stock tip Judo Capital Holdings

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News